Limitations, agreements, and source contact

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation · Source last updated 2021-10-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

ebmtcsu@lumc.nl

organization

EBMT

phone

+31(0)715265005

title

Clinical Study Unit

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice